Novo in October 2024 took the extra step of arguing to the FDA that semaglutide is too complex to compound, asking the regulator to include the drug in its Demonstrable Difficulties for Compounding (DDC) listin turn keeping it out of reach for compounders even in times of shortage
So, those are the elements being one of the reasons why the oral weight loss was able to scale so quickly
Comparative Advantages and Limitations of Tripeptides and Larger Peptides in Biomedical Applications
Optimized body composition Mechanisms: Reduce body fat while preserving muscle Improve strength-to-weight ratio Better leverage and force application Enhanced muscle definition Peptides in this category: Growth hormone peptides (recomposition) AOD 9604 (fat loss without muscle loss) Semaglutide/Tirzepatide (weight management) Result: Leaner body = better relative strength and power output
In addition, some quinone compounds, such as -LAPachone and aloin, have similar effects on heart protection [182, 183]
10.1016/j.lfs.2022.121141 28 VillalbaA.Rodriguez-FernandezS.Perna-BarrullD.AmpudiaR